Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 66.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (4.615%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 66.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS UPDATES: Live Co achieves surge in interim revenue

Fri, 30th Sep 2022 14:46

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

DG Innovate PLC - Bingley-England based storage battery manufacturer - Says grant income in the six months ended on June 30 falls to GBP344,831, from GBP675,816 a year ago. Pretax loss widens to GBP6.2 million from just GBP201,156, as administrative expenses jump to GBP1.2 million from GBP777,670 a year ago. "The first half of 2022 was transformational for the company, as we completed the reverse takeover of DGI to become DG Innovate PLC", Chair Nick Tulloch says. Looking ahead, it seeks to commercialise a suite of electric mobility and storage tech.

----------

Live Co Group PLC - UK-based live events and entertainment company - Posts a surge in revenue to GBP2.6 million for the six months ended on June 30, from GBP622,000 a year ago, as pretax loss narrows to GBP1.4 million from GBP2.1 million. Cost of sales increase to GBP1.7 million from GBP1.4 million a year earlier. Looking ahead, says it remains "cautiously optimistic" for 2023, citing increased demand for live events.

----------

NetScientific PLC - London-based life sciences and sustainability technology investment firm - Reports a fall in revenue to GBP391,000 for the six months ended June 30, from GBP407,000 a year ago. Pretax loss widens to GBP1.7 million from GBP1.5 million. Selling and administrative costs amount to GBP1.4 million, up from GBP1.2 million ago, mainly due to "increased headcount in the subsidiaries and at head office, and increased spending in drives towards commercialisation and eventual liquidity events".

----------

TechFinancials Inc - invests in early-stage technology companies - Posts no revenue for the six months ended on June 30. Pretax loss widens to USD163,000 from USD92,000 a year ago as financing expenses swing to a loss of USD89,000 from a profit of USD41,000.

----------

Apollon Formularies PLC - London-based medical cannabis pharmaceutical firm - Posts revenue of GBP165,053 in the six months ended on June 30, compared to none a year ago. Pretax loss narrows to GBP212,436 from GBP1.7 million, despite administrative expenses rising to GBP535,889 from GBP335,425 a year ago. No finance costs have incurred this year, compared to GBP3,799 last year.

-----------

By Xindi Wei; xindiwei@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
27 Jul 2020 22:01

IN BRIEF: NetScientific's PDS Sees Robust Data For Covid-19 Vaccine

IN BRIEF: NetScientific's PDS Sees Robust Data For Covid-19 Vaccine

Read more
14 Jul 2020 20:12

IN BRIEF: NetScientific's PDS Gets Green Light To Develop Vaccine

IN BRIEF: NetScientific's PDS Gets Green Light To Develop Vaccine

Read more
29 Jun 2020 21:02

IN BRIEF: NetScientific's G-Tech Secures USD6.7 Million Funding

IN BRIEF: NetScientific's G-Tech Secures USD6.7 Million Funding

Read more
18 Jun 2020 19:03

IN BRIEF: NetScientific Investee PDS Inks Covid Pact With Farmacore

IN BRIEF: NetScientific Investee PDS Inks Covid Pact With Farmacore

Read more
18 Jun 2020 10:21

NetScientific's PDS investment signs deal for Covid-19 vaccine

(Sharecast News) - NetScientific said one of its portfolio companies had signed a deal to speed up development of a potential Covid-19 vaccine.

Read more
15 Jun 2020 15:44

IN BRIEF: NetScientific's PDS Kicks Off Study For PDS0101 Cancer Drug

IN BRIEF: NetScientific's PDS Kicks Off Study For PDS0101 Cancer Drug

Read more
5 Jun 2020 11:21

UK WINNERS & LOSERS SUMMARY: Taylor Wimpey Up On Strong Client Demand

UK WINNERS & LOSERS SUMMARY: Taylor Wimpey Up On Strong Client Demand

Read more
27 Apr 2020 11:15

NetScientific Reports Narrowed Annual Loss On Lower Costs

NetScientific Reports Narrowed Annual Loss On Lower Costs

Read more
17 Apr 2020 11:19

UK WINNERS & LOSERS SUMMARY: Foxtons Seeks Placing To Avoid Crisis

UK WINNERS & LOSERS SUMMARY: Foxtons Seeks Placing To Avoid Crisis

Read more
17 Apr 2020 08:12

LONDON BRIEFING: Whiff Of Covid-19 Cure Sends Pharma Stocks Soaring

LONDON BRIEFING: Whiff Of Covid-19 Cure Sends Pharma Stocks Soaring

Read more
17 Apr 2020 06:56

NetScientific Investee PDS Biotechnology To Develop Covid-19 Vaccine

NetScientific Investee PDS Biotechnology To Develop Covid-19 Vaccine

Read more
12 Feb 2020 13:13

NetScientific To Invest Further USD650,000 In PDS Biotechnology

NetScientific To Invest Further USD650,000 In PDS Biotechnology

Read more
11 Feb 2020 15:51

NetScientific Mulls GBP500,000 Investment In PDS Biotech Fundraise

NetScientific Mulls GBP500,000 Investment In PDS Biotech Fundraise

Read more
15 Jan 2020 12:04

NetScientific CEO And CFO Ian Postlethwaite To Step Down In July

NetScientific CEO And CFO Ian Postlethwaite To Step Down In July

Read more
18 Dec 2019 19:08

Woodford Transfers Series Of Holdings To New Manager Schroders

Woodford Transfers Series Of Holdings To New Manager Schroders

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.